介质素-1β 干扰 保护雄性小鼠免受心力衰竭 通过保存的喷射小部分病原体
Balaji K Srinivas1, Aya Bourdi1, Jacob D O'Regan1
1Department of Physiological Sciences EVMS Norfolk VA USA.
Journal of the American Heart Association
|June 22, 2023
概括
介质素-1β通过促进炎症和内质网膜应激驱动心力衰竭与保存的喷射分数 (HFpEF). 在小鼠中,对抗HFpEF发展的互白素-1β的遗传删除.
科学领域:
- 心血管医学 心血管医学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 保存喷射分数的心力衰竭 (HFpEF) 是一种复杂的心血管疾病,治疗选择有限.
- 介质蛋白-1β (IL-1β) 在HFpEF病原发生中的特定作用尚不清楚.
- 了解IL-1β的机制对于开发针对HFpEF的向治疗至关重要.
研究的目的:
- 调查介质素-1β在心力衰竭与保留喷射分数 (HFpEF) 的发展中的作用和机制.
- 为了确定interleukin-1β的遗传干扰是否可以防止HFpEF的发病.
主要方法:
- 使用了C57/Bl6J和中白素-1β淘汰 (IL-1β-/-) 的雄性小鼠.
- 使用高脂肪饮食与内皮氧化合成酶抑制剂相结合,诱导HFpEF.
- 评估了各种生理和分子参数,包括心脏功能,炎症和内质网膜压力.
主要成果:
- 接受高脂肪饮食和抑制剂的小鼠产生了HFpEF特征:肥胖,糖尿病,高血压,心脏缩和内皮功能障碍.
- 对白内素-1β的遗传删除显著保护小鼠免受HFpEF的发展.
- 缺少IL-1β调节了炎症和内质网膜应激通路,减轻了HFpEF的发展.
结论:
- 干白素-1β在HFpEF病原发生过程中起到关键的作用.
- 通过IL-1β调节炎症和内细胞网膜应激,是HFpEF的一个关键机制.
- IL-1β代表了治疗心力衰竭的潜在治疗点,使用保存的喷射分数来治疗心力衰竭.
相关概念视频
Heart Failure II: Pathophysiology
16
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Pathophysiology of Heart Failure
1.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K


